Won Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Won Choi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Hyung Jin Hahn
Department of Dermatology, College of Medicine, Konyang University, Daejeon, Korea
1 shared publication - Joon Soo Lim
Department of Dermatology, Konyang University College of Medicine, Daejeon, Korea
1 shared publication - Ki Bum Myung
Department of Dermatology, College of Medicine, Konyang University, Daejeon, Korea
1 shared publication - Kyoung Geun Lee
Department of Dermatology, College of Medicine, Konyang University, Daejeon, Korea
1 shared publication - Seung Hyun Cheong
Department of Dermatology, College of Medicine, Konyang University, Daejeon, Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2019
- Published by XMLink in Annals of Dermatology
- Vol. 31 (5) , 559-562
Syringocystadenocarcinoma Papilliferum: A Case Report and Review of the Literature
Syringocystadenocarcinoma papilliferum (SCACP) is a rare malignant adnexal neoplasm, which is considered as a malignant counterpart of syringocystadenoma papilliferum (SCAP). Clinically, SCACP appears as a nodule, inflammatory plaque, or tumor. The lesion is usually covered with crusts, which are formed by secretion of the apocrine epithelial cells. Histologically, SCACP resembles SCAP, with cystic papillomatous invaginations connected to the skin surface by funnel-shaped structures lined by infundibular epithelium. The stroma of the tumor consists of a dense inflammatory infiltrate of plasma cells and lymphocytes. SCACP differs from SCAP in terms of the architectural and cytological features of the tumor cells, and is characterized by higher nuclear cytoplasmic ratio, nuclear irregularity, coarse chromatin, and increased mitotic activity. However, the immunohistochemical findings of SCACP vary. Since only 49 cases of SCACP have been reported in the English literature, the clinical and histologic characteristics of SCACP have not been fully established. Further studies on the diagnostic criteria for SCACP are warranted. Here, we report a rare case of SCACP and present a review of other relevant literature.
- 1 January 2019
- Published by XMLink in Annals of Dermatology
- Vol. 31 (5) , 559-562
Open AccessSyringocystadenocarcinoma Papilliferum: A Case Report and Review of the Literature
Syringocystadenocarcinoma papilliferum (SCACP) is a rare malignant adnexal neoplasm, which is considered as a malignant counterpart of syringocystadenoma papilliferum (SCAP). Clinically, SCACP appears as a nodule, inflammatory plaque, or tumor. The lesion is usually covered with crusts, which are formed by secretion of the apocrine epithelial cells. Histologically, SCACP resembles SCAP, with cystic papillomatous invaginations connected to the skin surface by funnel-shaped structures lined by infundibular epithelium. The stroma of the tumor consists of a dense inflammatory infiltrate of plasma cells and lymphocytes. SCACP differs from SCAP in terms of the architectural and cytological features of the tumor cells, and is characterized by higher nuclear cytoplasmic ratio, nuclear irregularity, coarse chromatin, and increased mitotic activity. However, the immunohistochemical findings of SCACP vary. Since only 49 cases of SCACP have been reported in the English literature, the clinical and histologic characteristics of SCACP have not been fully established. Further studies on the diagnostic criteria for SCACP are warranted. Here, we report a rare case of SCACP and present a review of other relevant literature.